Search results

This quality standard covers assessing, diagnosing and managing rheumatoid arthritis in over 16s. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Last updated

9 January 2020

This guideline covers diagnosing and managing rheumatoid arthritis. It aims to improve quality of life by ensuring that people with rheumatoid arthritis have the right treatment to slow the progression of their condition and control their symptoms. People should also have rapid access to specialist care if their condition suddenly worsens.

Result type

NICE guideline

Last updated

12 October 2020

Evidence-based recommendations on artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis. This involves removing the diseased joints and replacing them with artificial ones.

Result type

HealthTech guidance

Published

23 February 2005

NICE has developed a medtech innovation briefing (MIB) on LARS for reconstructing damaged intra-articular cruciate knee ligaments

Result type

Medtech innovation briefing

Published

22 May 2015

Evidence-based recommendations on computed tomography-guided thermocoagulation of osteoid osteoma. This involves using high-frequency energy to heat the growth and destroy it.

Result type

HealthTech guidance

Published

24 March 2004

presentation can be highly variable; most people with RA have definite synovitis on clinical assessment, but sometimes this is not...

Result type

Research recommendation

Published

11 December 2018

activity, it may be unclear if the person has subclinical inflammatory synovitis or more of a widespread pain syndrome, which is not...

Result type

Research recommendation

Published

11 December 2018

Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Remsima, Inflectra), certolizumab pegol (Cimzia), golimumab (Simponi), tocilizumab (RoActemra) and abatacept (Orencia). These drugs are for adults with severe rheumatoid arthritis who have tried conventional DMARDs only but they have not worked.

Result type

Technology appraisal guidance

Published

26 January 2016

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Result type

HealthTech guidance

Published

10 July 2019